cyclosporine and Vascular Diseases

cyclosporine has been researched along with Vascular Diseases in 47 studies

Research

Studies (47)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's22 (46.81)18.2507
2000's17 (36.17)29.6817
2010's7 (14.89)24.3611
2020's1 (2.13)2.80

Authors

AuthorsStudies
Ahmed, RM; Maamoun, H; Soliman, AR; Soliman, H1
Brennan, J; Coulston, J; Kennedy, T; Millen, A1
Andersson, B; Andreassen, AK; Arora, S; Aukrust, P; Bøtker, HE; Dellgren, G; Eiskjaer, H; Erikstad, I; Gude, E; Gullestad, L; Gustafsson, F; Ioanes, D; Rådegran, G; Sigurdardottir, V; Solberg, OG; Solbu, D; Ueland, T1
Andersson, B; Andreassen, AK; Arora, S; Dellgren, G; Eiskjaer, H; Gude, E; Gullestad, L; Gustafsson, F; Jansson, K; Karason, K; Rådegran, G; Solbu, D1
Bu, H; Wang, J; Wang, W; Zhang, P1
Hirsch, GM; Lee, TD; Zaki, AM1
Gareau, A; Hirsch, GM; Lee, TD; Nashan, B1
Böhmer, AE; Brum, LM; Hansel, G; Portela, LV; Souza, DG; Souza, DO1
Agüero, J; Almenar-Bonet, L; Buendía-Fuentes, F; Martínez-Dolz, L; Navarro-Manchón, J; Raso-Raso, R; Salvador-Sanz, A; Sánchez-Lázaro, IJ1
Gareau, AJ; Hirsch, GM; Lee, TD; Nashan, B1
Chadban, SJ; Eris, JM; Hambly, BD; Ko, HT; Wu, H; Wyburn, K; Yin, JL1
Barten, M; Gummert, J; Mohr, FW; Olbrich, HG; Richter, H; Richter, MH; Schramm, D; Weinert, M1
Bruijn, JA; Claas, FH; de Fijter, JW; Doxiadis, II; Paul, LC; Sijpkens, YW; van Kemenade, FJ; Zwinderman, AH1
Bruch, D; Da Silva, M; Kittur, DS; Kittur, S; Siddiqui, J; Singh, B; Wilasrusmee, C; Wilasrusmee, S1
Brazzola, P; Champagne, J; Champagne, MA; Dalle, JH; Duval, M; Fournet, JC; Gauvin, F1
Brown, L; Coombes, JS; Fassett, RG; Fenning, A; Lexis, LA1
Bailey, L; Beeson, WL; Chinnock, RE; Fitts, J; Hathout, E; Johnston, J; Kuhn, M; Razzouk, A1
Schut, NH1
Ayala, JM; Azimzadeh, AM; DeMartino, JA; Iliff, S; Kawka, DW; Lu, M; Lyons, K; Miller, GG; Mills, SG; Mudgett, JS; Nguyen, BN; Peterson, LB; Pierson, RN; Schröder, C; Siciliano, SJ; Singer, II; Springer, MS; Wu, G; Zhang, T1
Branzoli, SE; McGregor, CG; Miyagi, N; O'Brien, T; Rao, VP; Ricci, D; Russell, SJ; Tazelaar, HD1
Bang, D; Bodaghi, B; Chamberlain, AM; Gul, A; Hatemi, G; Houman, MH; Kötter, I; Olivieri, I; Salvarani, C; Sfikakis, PP; Silman, A; Siva, A; Stanford, MR; Stübiger, N; Yazici, H; Yurdakul, S1
Habuchi, T; Inoue, K; Inoue, T; Kagaya, H; Komatsuda, A; Kumazawa, T; Miura, M; Obara, T; Saito, M; Satoh, S; Tsuchiya, N; Tsuruta, H; Yuasa, T1
Brugger, S; Greinix, HT; Höcker, P; Kalhs, P; Keil, F; Knöbl, P; Kyrle, PA; Linkesch, W; Schneider, B; Schwarzinger, I1
Alpers, CE; Andoh, T; Bennett, WM; Burdmann, EA; Couser, WG; Johnson, RJ; Young, BA1
Azuma, H; Heemann, U; Schmid, C; Tilney, NL1
Bradstock, KF; Gottlieb, D; Srivastava, A1
Mihatsch, MJ; Strøm, EH; Thiel, G1
Becker, GJ; Choy, BY; Walker, RG1
Charba, D; Harris, MA; Hester, JP; Moake, JL1
Alexander, JW; Demmy, AM; First, MR; Hariharan, S; Munda, R; Schroeder, TJ1
de Ridder, L; Lameire, N; Van de Voorde, J; Verbeke, M1
Cardella, C; Cattran, D; Cole, E; Fenton, S; Katz, A; Quaggin, S; Wade, J; Zaltzman, J; Zent, R1
Heemann, U; Schmid, C; Tilney, NL1
Hishida, A; Matsushima, H1
Andoh, TF; Bennett, WM; Gardner, MP1
Ding, XQ; Hatori, M; Kokado, Y; Kyakuno, M; Kyo, M; Miki, T; Miyamoto, M; Nakamura, T; Okada, M; Okuyama, A; Takahara, S; Toki, K1
Ichimaru, N; Imai, E; Kokado, Y; Kyakuno, M; Kyo, M; Nakamura, T; Namba, Y; Oka, K; Okada, M; Okuyama, A; Takahara, S; Toki, K; Yamashiro, H1
Bosch, T; Buhmann, R; Kolb, HJ; Lennertz, A; Samtleben, W1
Allan, JS; Aretz, HT; Choo, JK; Erhorn, AE; Madsen, JC; Mawulawde, K; Menard, MT; Sachs, DH; Shimizu, A; Slisz, JK; Yamada, K1
Goldstein, J; Goyal, M; Mallory, GB; Wong, M; Yamada, KA1
Ichimaru, N; Imai, E; Kojima, Y; Kokado, Y; Kyakuno, M; Kyo, M; Miyamoto, M; Morozumi, K; Nakamura, T; Oka, K; Okuyama, A; Permpongkosol, S; Takahara, S; Tanaka, T; Toki, K; Wang, JD1
Baan, CC; Balk, AH; de Groot-Kruseman, HA; Loonen, EH; Maat, AP; Mol, WM; Niesters, HG; Weimar, W1
Benamenyo, JP; Droz, D; Niaudet, P1
Hiller, E; Holler, E; Kolb, HJ; Seeber, C1
Alpers, CE; Collins, BS; Davis, CL; Marsh, CL; McVicar, JP; Perkins, JD1
Albert, FW; Banfi, G; Gudat, F; Mihatsch, MJ; Morozumi, K; Thiel, G1
Berkenboom, G; Fang, ZY; Fontaine, J; Goldman, M; Unger, P1

Reviews

1 review(s) available for cyclosporine and Vascular Diseases

ArticleYear
[Cyclosporine nephrotoxicity (chronic arteriolopathy, glomerulopathy)].
    Ryoikibetsu shokogun shirizu, 1997, Issue:16 Pt 1

    Topics: Chronic Disease; Cyclosporine; Humans; Immunosuppressive Agents; Kidney; Kidney Diseases; Kidney Glomerulus; Vascular Diseases

1997

Trials

6 trial(s) available for cyclosporine and Vascular Diseases

ArticleYear
Steroid resistant focal segmental glomerulosclerosis: effect of arterial hyalinosis on outcome: single center study.
    Romanian journal of internal medicine = Revue roumaine de medecine interne, 2021, Jun-01, Volume: 59, Issue:2

    Topics: Adult; Arterioles; Blood Pressure; Cyclosporine; Diarrhea; Drug Resistance; Drug Therapy, Combination; Eye Diseases, Hereditary; Female; Fibrosis; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucocorticoids; Humans; Hyalin; Immunosuppressive Agents; Intestinal Diseases; Male; Mycophenolic Acid; Prednisolone; Prospective Studies; Proteinuria; Skin Abnormalities; Treatment Outcome; Vascular Diseases

2021
The Effect of Everolimus Initiation and Calcineurin Inhibitor Elimination on Cardiac Allograft Vasculopathy in De Novo Recipients: One-Year Results of a Scandinavian Randomized Trial.
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2015, Volume: 15, Issue:7

    Topics: Adult; Allografts; Calcineurin Inhibitors; Cyclosporine; Drug Therapy, Combination; Everolimus; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Heart Diseases; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Postoperative Complications; Prognosis; Risk Factors; Sirolimus; Transplant Recipients; Vascular Diseases

2015
Everolimus Initiation With Early Calcineurin Inhibitor Withdrawal in De Novo Heart Transplant Recipients: Three-Year Results From the Randomized SCHEDULE Study.
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2016, Volume: 16, Issue:4

    Topics: Adolescent; Adult; Aged; Allografts; Calcineurin Inhibitors; Cyclosporine; Everolimus; Female; Follow-Up Studies; Glomerular Filtration Rate; Graft Rejection; Graft Survival; Heart Diseases; Heart Transplantation; Humans; Immunosuppressive Agents; Kidney Function Tests; Male; Middle Aged; Postoperative Complications; Prognosis; Prospective Studies; Risk Factors; Transplant Recipients; Vascular Diseases; Withholding Treatment; Young Adult

2016
Preliminary results of a prospective randomized study of cyclosporine versus tacrolimus in the development of cardiac allograft vasculopathy at 1 year after heart transplantation.
    Transplantation proceedings, 2010, Volume: 42, Issue:8

    Topics: Cyclosporine; Heart Transplantation; Humans; Immunosuppressive Agents; Prospective Studies; Tacrolimus; Vascular Diseases

2010
Conversion from cyclosporine to tacrolimus after pancreas transplantation.
    Transplantation proceedings, 1995, Volume: 27, Issue:6

    Topics: Adult; Cyclosporine; Female; Graft Rejection; Humans; Kidney; Kidney Transplantation; Male; Middle Aged; Pancreas Transplantation; Reoperation; Safety; Tacrolimus; Vascular Diseases

1995
Morphological findings in non-episode biopsies of kidney transplant allografts treated with FK506 or cyclosporine.
    Transplant international : official journal of the European Society for Organ Transplantation, 1998, Volume: 11 Suppl 1

    Topics: Biopsy; Cyclosporine; Humans; Immunosuppressive Agents; Kidney; Kidney Diseases; Kidney Transplantation; Postoperative Complications; Tacrolimus; Vascular Diseases

1998

Other Studies

40 other study(ies) available for cyclosporine and Vascular Diseases

ArticleYear
The use of immunosuppressive agents in the management of recalcitrant lower limb ulcers.
    Journal of wound care, 2014, Volume: 23, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Chronic Disease; Cyclophosphamide; Cyclosporine; Female; Hospitals, University; Humans; Immunomodulation; Immunosuppressive Agents; Leg Ulcer; Lower Extremity; Male; Middle Aged; Tertiary Care Centers; Treatment Outcome; Vascular Diseases; Wound Healing

2014
Cyclosporine A aggravates vascular endothelial injury in hyperlipidemic rats by down-regulating decay-accelerating factor.
    Biochemical and biophysical research communications, 2009, Jan-30, Volume: 379, Issue:1

    Topics: Animals; CD55 Antigens; Cells, Cultured; Cyclosporine; Endothelium, Vascular; Humans; Hyperlipidemias; Immunosuppressive Agents; Male; Rats; Rats, Wistar; Umbilical Cord; Vascular Diseases; Vascular Endothelial Growth Factor A

2009
Contribution of pre-existing vascular disease to allograft vasculopathy in a murine model.
    Transplant immunology, 2009, Volume: 22, Issue:1-2

    Topics: Animals; Aorta; Apolipoproteins E; Atherosclerosis; CD4-Positive T-Lymphocytes; Cyclosporine; Disease Models, Animal; Foam Cells; Graft Rejection; Green Fluorescent Proteins; Macrophages; Male; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Tissue Donors; Transplantation, Homologous; Tunica Intima; Tunica Media; Vascular Diseases

2009
Contribution of B cells and antibody to cardiac allograft vasculopathy.
    Transplantation, 2009, Aug-27, Volume: 88, Issue:4

    Topics: Actins; Animals; Antibody-Dependent Cell Cytotoxicity; Aorta, Abdominal; B-Lymphocytes; Cyclosporine; Disease Models, Animal; Heart Transplantation; Homeodomain Proteins; Humans; Immunization, Passive; Immunosuppressive Agents; In Vitro Techniques; Isoantibodies; Lymphocyte Depletion; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Knockout; Transplantation, Homologous; Vascular Diseases

2009
Long-term cyclosporine treatment in non-transplanted rats and metabolic risk factors of vascular diseases.
    Chemico-biological interactions, 2010, Apr-15, Volume: 185, Issue:1

    Topics: Animals; Blood Coagulation; Body Weight; Cyclosporine; Fibrinogen; Glucose Tolerance Test; Homocysteine; Humans; Immunosuppressive Agents; Insulin; Leptin; Lipids; Male; Rats; Rats, Wistar; Risk Factors; Vascular Diseases

2010
Cyclosporine immunosuppression does not prevent the production of donor-specific antibody capable of mediating allograft vasculopathy.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2012, Volume: 31, Issue:8

    Topics: Animals; Antibody Specificity; Calcineurin Inhibitors; Cyclosporine; Graft Rejection; Heart Transplantation; Immunosuppressive Agents; Isoantibodies; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Models, Animal; T-Lymphocytes; Tissue Donors; Transplantation, Homologous; Vascular Diseases

2012
Sirolimus reduces vasculopathy but exacerbates proteinuria in association with inhibition of VEGF and VEGFR in a rat kidney model of chronic allograft dysfunction.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2013, Volume: 28, Issue:2

    Topics: Animals; Cell Proliferation; Cells, Cultured; Cyclosporine; Disease Models, Animal; Immunosuppressive Agents; In Vitro Techniques; Kidney Transplantation; Male; Podocytes; Proteinuria; Rats; Rats, Inbred F344; Rats, Inbred Lew; Receptors, Vascular Endothelial Growth Factor; Signal Transduction; Sirolimus; Transplantation, Homologous; Vascular Diseases; Vascular Endothelial Growth Factor A

2013
Cyclosporin A does not enhance the development of transplant vasculopathy: experimental study in a rat cardiac transplant model.
    Transplantation proceedings, 2002, Volume: 34, Issue:5

    Topics: Animals; Coronary Stenosis; Cyclosporine; Graft Rejection; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Postoperative Complications; Rats; Rats, Inbred F344; Rats, Inbred Lew; Vascular Diseases

2002
Chronic rejection with or without transplant vasculopathy.
    Clinical transplantation, 2003, Volume: 17, Issue:3

    Topics: Acute Disease; Adult; Atrophy; Chronic Disease; Cohort Studies; Cyclosporine; Fibrosis; Graft Rejection; Graft Survival; Humans; Kidney Transplantation; Kidney Tubules; Logistic Models; Risk Factors; Time Factors; Vascular Diseases

2003
Morphological and biochemical effects of immunosuppressive drugs in a capillary tube assay for endothelial dysfunction.
    Clinical transplantation, 2003, Volume: 17 Suppl 9

    Topics: Cell Survival; Cyclosporine; Dexamethasone; Endothelin-1; Endothelium, Vascular; Epoprostenol; Humans; Immunosuppressive Agents; In Vitro Techniques; Mycophenolic Acid; Sirolimus; Tacrolimus; Vascular Diseases

2003
Fatal diffuse capillaritis after hematopoietic stem-cell transplantation for dyskeratosis congenita despite low-intensity conditioning regimen.
    Bone marrow transplantation, 2005, Volume: 36, Issue:12

    Topics: Adolescent; Capillaries; Cerebral Hemorrhage; Cyclosporine; Dyskeratosis Congenita; Erythrocyte Transfusion; Esophagus; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Male; Mucous Membrane; Necrosis; Platelet Transfusion; Time Factors; Transplantation Conditioning; Vascular Diseases

2005
Antioxidant supplementation enhances erythrocyte antioxidant status and attenuates cyclosporine-induced vascular dysfunction.
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2006, Volume: 6, Issue:1

    Topics: alpha-Tocopherol; Animals; Antioxidants; Aorta, Thoracic; Creatinine; Cyclosporine; Dietary Supplements; Erythrocytes; Glutathione; Immunosuppressive Agents; Male; Malondialdehyde; Methemoglobin; Rats; Rats, Sprague-Dawley; Superoxides; Thioctic Acid; Vascular Diseases

2006
Cardiac allograft vasculopathy in pediatric heart transplant recipients.
    Transplant international : official journal of the European Society for Organ Transplantation, 2006, Volume: 19, Issue:3

    Topics: Adolescent; Angiography; Autopsy; Child; Child, Preschool; Cholesterol; Cyclosporine; Female; Glucose; Graft Survival; Heart Transplantation; Hemodynamics; HLA-DR Antigens; Humans; Immunosuppressive Agents; Infant; Infant, Newborn; Lipids; Lipoproteins, LDL; Logistic Models; Male; Models, Statistical; Multivariate Analysis; Odds Ratio; Proportional Hazards Models; Regression Analysis; Time Factors; Treatment Outcome; Vascular Diseases

2006
Vascular injury mediated by calcineurin inhibitors: contribution of rheological factors?
    Kidney international, 2006, Volume: 69, Issue:10

    Topics: Calcineurin Inhibitors; Cyclosporine; Endothelium, Vascular; Erythrocyte Deformability; Hemorheology; Humans; Hypertension; Immunosuppressive Agents; Shear Strength; Vascular Diseases; Vascular Resistance

2006
CCR5 blockade modulates inflammation and alloimmunity in primates.
    Journal of immunology (Baltimore, Md. : 1950), 2007, Aug-15, Volume: 179, Issue:4

    Topics: Animals; Antibody Formation; Autoimmunity; CCR5 Receptor Antagonists; Cyclosporine; Disease Models, Animal; Graft Survival; Heart Transplantation; HIV Infections; Humans; Immunosuppressive Agents; Inflammation; Isoantibodies; Kidney Transplantation; Macaca fascicularis; Macrophages; Male; Pyrazoles; Stress, Physiological; T-Lymphocytes; Transplantation Tolerance; Transplantation, Homologous; Valine; Vascular Diseases

2007
Recombinant adenoviral gene transfer does not affect cardiac allograft vasculopathy.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2007, Volume: 26, Issue:12

    Topics: Adenoviridae; Animals; Cyclosporine; Gene Transfer Techniques; Genetic Therapy; Genetic Vectors; Graft Rejection; Heart Transplantation; Immunosuppressive Agents; Random Allocation; Rats; Rats, Inbred BN; Rats, Inbred Lew; Time Factors; Vascular Diseases

2007
EULAR recommendations for the management of Behçet disease.
    Annals of the rheumatic diseases, 2008, Volume: 67, Issue:12

    Topics: Anticoagulants; Arthritis; Behcet Syndrome; Cyclosporine; Evidence-Based Medicine; Gastrointestinal Diseases; Humans; International Cooperation; Nervous System Diseases; Skin Diseases; Uveitis; Vascular Diseases

2008
Thrombotic microangiopathy developing in early stage after renal transplantation with a high trough level of tacrolimus.
    Clinical and experimental nephrology, 2008, Volume: 12, Issue:4

    Topics: Cyclosporine; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Middle Aged; Tacrolimus; Vascular Diseases

2008
Microangiopathy following allogeneic marrow transplantation. Association with cyclosporine and methylprednisolone for graft-versus-host disease prophylaxis.
    Transplantation, 1995, Nov-15, Volume: 60, Issue:9

    Topics: Adult; Bone Marrow Transplantation; Cyclosporine; Female; Follow-Up Studies; Graft Survival; Graft vs Host Disease; Hemolysis; Humans; Hypertension; Immunosuppressive Agents; L-Lactate Dehydrogenase; Male; Methotrexate; Methylprednisolone; Middle Aged; Nervous System Diseases; Plasmapheresis; Platelet Count; Retrospective Studies; Syndrome; Transplantation, Homologous; Vascular Diseases

1995
Cyclosporine A induced arteriolopathy in a rat model of chronic cyclosporine nephropathy.
    Kidney international, 1995, Volume: 48, Issue:2

    Topics: Animals; Arterioles; Chronic Disease; Cyclosporine; Diet, Sodium-Restricted; Kidney Diseases; Male; Microscopy, Electron; Rats; Rats, Sprague-Dawley; Vascular Diseases

1995
Rapamycin inhibits transplant vasculopathy in long-surviving rat heart allografts.
    Transplantation, 1995, Oct-15, Volume: 60, Issue:7

    Topics: Animals; Cell Division; Cyclosporine; Dose-Response Relationship, Drug; Heart Transplantation; Immunohistochemistry; Immunosuppressive Agents; Male; Polyenes; Rats; Rats, Inbred F344; Rats, Inbred Lew; Sirolimus; Time Factors; Tunica Intima; Vascular Diseases; Ventricular Function

1995
Diffuse alveolar haemorrhage associated with microangiopathy after allogeneic bone marrow transplantation.
    Bone marrow transplantation, 1995, Volume: 15, Issue:6

    Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Endothelium, Vascular; Fatal Outcome; Female; Hemolytic-Uremic Syndrome; Hemorrhage; Humans; Leukemia, Myeloid; Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative; Lung Diseases; Lymphoma, Non-Hodgkin; Male; Plasma; Plasmapheresis; Platelet Transfusion; Pulmonary Alveoli; Purpura, Thrombotic Thrombocytopenic; Respiratory Insufficiency; Transplantation, Homologous; Vascular Diseases

1995
Prevalence of cyclosporine-associated arteriolopathy in renal transplant biopsies from 1981 to 1992.
    Transplantation proceedings, 1994, Volume: 26, Issue:5

    Topics: Arterioles; Cyclosporine; Humans; Kidney Transplantation; Prevalence; Retrospective Studies; Time Factors; Transplantation, Homologous; Treatment Failure; Vascular Diseases

1994
Vasculopathy in cyclosporine-treated renal allografts: possible protection by diltiazem.
    Clinical transplantation, 1994, Volume: 8, Issue:3 Pt 1

    Topics: Adult; Arterioles; Azathioprine; Cyclosporine; Diltiazem; Female; Humans; Image Processing, Computer-Assisted; Kidney; Kidney Transplantation; Male; Prednisolone; Vascular Diseases

1994
Abnormalities of von Willebrand factor multimers in drug-associated thrombotic microangiopathies.
    American journal of hematology, 1993, Volume: 42, Issue:3

    Topics: Adolescent; Adult; Aged; Antigens; Cyclosporine; Electrophoresis, Agar Gel; Female; Humans; Male; Microcirculation; Polymers; Sodium Dodecyl Sulfate; Thrombosis; Vascular Diseases; von Willebrand Factor

1993
Regional differences in vasculotoxic effects of cyclosporin in rats.
    Canadian journal of physiology and pharmacology, 1995, Volume: 73, Issue:11

    Topics: Acetylcholine; Animals; Aorta; Carotid Arteries; Cyclosporine; Endothelium, Vascular; Immunosuppressive Agents; In Vitro Techniques; Kidney Diseases; Male; Muscle Contraction; Muscle, Smooth, Vascular; Nitroglycerin; Nitroprusside; Rats; Rats, Wistar; Renal Artery; Vascular Diseases; Vasodilator Agents

1995
Thrombotic microangiopathy in renal transplant recipients treated with cyclosporin A.
    Clinical nephrology, 1997, Volume: 47, Issue:3

    Topics: Adolescent; Adult; Biopsy; Cyclosporine; Humans; Kidney; Kidney Transplantation; Microcirculation; Middle Aged; Prognosis; Retrospective Studies; Thrombosis; Vascular Diseases

1997
Factors contributing to the development of chronic rejection in heterotopic rat heart transplantation.
    Transplantation, 1997, Jul-27, Volume: 64, Issue:2

    Topics: Animals; Chronic Disease; Cyclosporine; Dose-Response Relationship, Drug; Graft Rejection; Heart Transplantation; Histocompatibility Testing; Immunosuppressive Agents; Male; Myocardial Reperfusion Injury; Polyenes; Rats; Rats, Inbred BN; Rats, Inbred F344; Rats, Inbred Lew; Sirolimus; Transplantation, Heterotopic; Vascular Diseases

1997
Protective effects of dietary L-arginine supplementation on chronic cyclosporine nephrotoxicity.
    Transplantation, 1997, Nov-15, Volume: 64, Issue:9

    Topics: Animals; Arginine; Blood Pressure; Cyclosporine; Enzyme Inhibitors; Fibrosis; Glomerular Filtration Rate; Immunosuppressive Agents; Kidney; Kidney Diseases; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Sprague-Dawley; Vascular Diseases

1997
[A case of subclinical IgA nephropathy and cyclosporin associated arteriolopathy diagnosed by non-episode biopsy of graft kidney after renal transplantation].
    Hinyokika kiyo. Acta urologica Japonica, 1999, Volume: 45, Issue:5

    Topics: Biopsy; Cyclosporine; Glomerulonephritis, IGA; Humans; Immunosuppressive Agents; Kidney; Kidney Transplantation; Male; Middle Aged; Renal Artery; Vascular Diseases

1999
Therapeutic plasma exchange in patients suffering from thrombotic microangiopathy after allogeneic bone marrow transplantation.
    Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis, 1999, Volume: 3, Issue:3

    Topics: Adult; Bone Marrow Transplantation; Cyclosporine; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Pilot Projects; Plasma Exchange; Retrospective Studies; Transplantation, Homologous; Treatment Outcome; Vascular Diseases

1999
The effect of thymectomy on tolerance induction and cardiac allograft vasculopathy in a miniature swine heart/kidney transplantation model.
    Transplantation, 1999, Aug-27, Volume: 68, Issue:4

    Topics: Animals; Cyclosporine; Heart Transplantation; Histocompatibility Antigens Class I; Immune Tolerance; Immunosuppressive Agents; Kidney Transplantation; Models, Biological; Swine; Swine, Miniature; Thymectomy; Thymus Gland; Transplantation, Homologous; Vascular Diseases

1999
Neurologic complications of pediatric lung transplantation.
    Neurology, 1999, Oct-22, Volume: 53, Issue:7

    Topics: Adolescent; Adult; Child; Child, Preschool; Cyclosporine; Female; Humans; Hypoxia; Immunosuppressive Agents; Infant; Infant, Newborn; Lung Transplantation; Male; Nervous System Diseases; Prognosis; Pulmonary Circulation; Pulmonary Fibrosis; Retrospective Studies; Risk Factors; Seizures; Stroke; Vascular Diseases

1999
Arteriolopathy in non-episode biopsies of renal transplant allograft.
    Clinical transplantation, 2000, Volume: 14 Suppl 3

    Topics: Adult; Biopsy; Chi-Square Distribution; Cyclosporine; Female; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Predictive Value of Tests; Statistics, Nonparametric; Tacrolimus; Vascular Diseases

2000
Failure to down-regulate intragraft cytokine mRNA expression shortly after clinical heart transplantation is associated with high incidence of acute rejection.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2001, Volume: 20, Issue:5

    Topics: Acute Disease; Biopsy; Chemokine CCL2; Cyclosporine; Cytokines; Endocardium; Fibroblast Growth Factor 2; Gene Expression Regulation; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Incidence; Ischemia; Myocardium; RNA, Messenger; Vascular Diseases

2001
One-year routine renal transplant biopsies in children.
    Pediatric nephrology (Berlin, Germany), 2001, Volume: 16, Issue:12

    Topics: Acute Disease; Adolescent; Adult; Aging; Biopsy; Child; Child, Preschool; Cryopreservation; Cyclosporine; Female; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Kidney; Kidney Diseases; Kidney Transplantation; Male; Postoperative Period; Renal Circulation; Time Factors; Vascular Diseases

2001
Increased levels of tissue plasminogen activator (t-PA) and tissue plasminogen activator inhibitor (PAI) correlate with tumor necrosis factor alpha (TNF alpha)-release in patients suffering from microangiopathy following allogeneic bone marrow transplanta
    Thrombosis research, 1992, May-15, Volume: 66, Issue:4

    Topics: Acute Disease; Adult; beta-Thromboglobulin; Bone Marrow Transplantation; Cyclosporine; Factor VIII; Fibrin Fibrinogen Degradation Products; Graft vs Host Disease; Humans; Microcirculation; Middle Aged; Plasminogen Activator Inhibitor 1; Platelet Factor 4; Prospective Studies; Severity of Illness Index; Tissue Plasminogen Activator; Transplantation, Autologous; Transplantation, Homologous; Tumor Necrosis Factor-alpha; Vascular Diseases; von Willebrand Factor

1992
Reversible cyclosporine arteriolopathy.
    Transplantation, 1992, Volume: 54, Issue:4

    Topics: Adult; Arterioles; Biopsy; Cyclosporine; Dose-Response Relationship, Drug; Drug Interactions; Fluconazole; Humans; Kidney Cortex; Kidney Transplantation; Male; Muscle, Smooth, Vascular; Pancreas Transplantation; Vascular Diseases

1992
Studies on morphological outcome of cyclosporine-associated arteriolopathy after discontinuation of cyclosporine in renal allografts.
    Clinical nephrology, 1992, Volume: 38, Issue:1

    Topics: Adult; Arterioles; Biopsy; Cyclosporine; Follow-Up Studies; Graft Survival; Humans; Kidney; Kidney Transplantation; Middle Aged; Time Factors; Treatment Outcome; Vascular Diseases

1992
Prevention of cyclosporine A-induced vascular toxicity by pentoxifylline.
    Journal of cardiovascular pharmacology, 1991, Volume: 18, Issue:5

    Topics: Acetylcholine; Animals; Arginine; Colforsin; Cyclosporine; Endothelium, Vascular; Male; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Neuromuscular Depolarizing Agents; Nitric Oxide; Nitroprusside; omega-N-Methylarginine; Pentoxifylline; Phenylephrine; Rats; Rats, Inbred Strains; Vascular Diseases

1991